COMMUNIQUÉS West-GlobeNewswire

Elias Zerhouni, President of Sanofi R&D, wins 'Executive of the Year' at annual Scrip Awards
30/11/2017
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Elias Zerhouni, President of Sanofi R&D, wins 'Executive of the Year' at annual Scrip Awards · Dr. Zerhouni credited with transforming Sanofi's R&D into a [...]
Elias Zerhouni, Président Monde de la R&D de Sanofi, nommé « Executive of the Year » aux Scrip Awards
30/11/2017
Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Elias Zerhouni, Président Monde de la R&D de Sanofi, nommé « Executive of the Year » aux Scrip Awards Cette distinction reconnaît le rôle joué par le [...]
Novartis' Cosentyx® is first biologic to show long-term efficacy in nail and palmoplantar psoriasis, which can impact up to 90% of psoriasis patients
30/11/2017
Unique Cosentyx ® (secukinumab) data reinforce treatment option for up to 90% of psoriasis patients who may develop nail or palmoplantar psoriasis[1] - [4] Cosentyx results represent the first data on biologic use for [...]
Probiodrug AG: Probiodrug reports Third Quarter 2017 Business Update
30/11/2017
HALLE (SAALE), Germany, 30 November 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), today announces its third quarter [...]
3D Signatures Reports First Quarter Financial Results for Fiscal 2018
30/11/2017
TORONTO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform based on the three- [...]
Teladoc Announces Pricing of Sale of Shares of Common Stock
30/11/2017
PURCHASE, NY, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE: TDOC ) (“Teladoc”) today announced the pricing of the previously announced offering of shares of its common stock, which includes 3,454,000 shares [...]
Dr. Stephen Hudis Sworn in as Vice President of the American College of Prosthodontists
29/11/2017
Chicago, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Stephen I. Hudis, DDS, FACP , was sworn in as Vice President of the American College of Prosthodontists (ACP) during the 47 th Annual Session of the ACP held in San Francisco, [...]
Novartis announces Phase III STRIVE data published in NEJM demonstrating significant and sustained efficacy of erenumab in migraine prevention
29/11/2017
Patients with episodic migraine taking erenumab reported significant and meaningful benefits over six months, with reduced migraine days and acute medication use Fifty percent of patients taking erenumab 140mg had their [...]
Forward Pharma Files Further Written Submissions in the European Opposition Proceeding for the EP2801355 Patent in Preparation for the Oral Hearing in January 2018
29/11/2017
COPENHAGEN, Denmark, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (“Forward” or the “Company”) today announced the filing of further written submissions in the European Opposition Proceeding for [...]
Veritas Pharma Appoints of BC's "Top 40 Under 40" Robert Dawson – a Highly Regarded Marketing & Innovation Expert to Its Advisory Board
29/11/2017
VANCOUVER, British Columbia, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) announces the appointment of Mr. Robert “Rob” Dawson to its [...]
Golden Leaf Reports Third Quarter 2017 Results
29/11/2017
TORONTO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced its [...]
TRACON Doses First Patient in Phase 1b Study of TRC105 with Opdivo® in Patients with Lung Cancer
29/11/2017
SAN DIEGO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
Adamis Pharmaceuticals Submits Prior Approval Supplement to FDA for the Pediatric Version of Symjepi
29/11/2017
SAN DIEGO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) today announced the submission of a prior approval supplement to the U.S. Food and Drug Administration (“FDA”) for a [...]
Genesis Healthcare, Inc. Receives Continued Listing Standard Notice From the NYSE
29/11/2017
KENNETT SQUARE, Pa., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Genesis HealthCare (“Genesis”) (NYSE: GEN ), one of the largest post-acute care providers in the United States, today announced that it received written [...]
Genmab Achieves USD 20 Million Milestone in Daratumumab Collaboration with Janssen and Updates Financial Guidance
29/11/2017
Company Announcement Genmab to receive USD 20 million milestone payment from Janssen Milestone triggered by progress in the Phase III study of daratumumab in combination with cyclophosphamide, bortezomib and [...]
Amphastar Announces Approval for Medroxyprogesterone Acetate Injectable Suspension, USP
29/11/2017
RANCHO CUCAMONGA, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH ) announced that today the U.S. Food and Drug Administration (“FDA”) granted approval of two abbreviated new [...]
Establishment Labs and OBP Medical Announce Partnership to Deliver Innovative New Tool for Advanced Breast Aesthetics Procedures
29/11/2017
NEW YORK, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today the launch [...]
Sanofi updates information on dengue vaccine
29/11/2017
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi updates information on dengue vaccine New analysis of long-term Dengvaxia ® data found differences in vaccine performance based on prior dengue infection [...]
Sanofi actualise l'information concernant son vaccin contre la dengue
29/11/2017
Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi actualise l'information concernant son vaccin contre la dengue Les résultats d'une nouvelle étude de suivi à long terme de Dengvaxia ® font [...]

Pages